Chief, Laboratory of Molecular Immunology
NIAID, NIH
Philip M. Murphy, M.D. is Chief of the Laboratory of Molecular Immunology in the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, NIH. Dr. Murphy received an AB in Biochemistry from Princeton and an MD from Cornell and was trained in Internal Medicine at NYU-Bellevue and in Infectious Diseases at the NIAID/NIH. His research focuses on basic, translational and clinical studies of G protein-coupled chemotactic receptors of the immune system with interests in inflammation, immunodeficiency and infectious diseases. His laboratory discovered the first human leukocyte chemoattractant receptors selective for neutrophils (CXCR2) and eosinophils (CCR3) as well as the first virally-encoded chemokine receptors, and demonstrated pathophysiologic roles in diseases ranging from HIV/AIDS to WHIM syndrome, a rare primary immunodeficiency disease caused by mutations in the chemokine receptor CXCR4. His work on WHIM syndrome includes clinical trials of drug treatment as well as preclinical development of gene therapy and allotransplantation cure strategies. He has published 331 papers in basic, translational and clinical immunology, two of which have been selected as Classics by Science Magazine and has been elected to the American Society for Clinical Investigation, the Association of American Physicians and the Henry Kunkel Society.
Disclosure information not submitted.
Monday, October 17, 2022
4:00 PM – 4:15 PM ET
Monday, October 17, 2022
4:15 PM – 4:30 PM ET